Low cardiac output syndrome

Article written and reviewed by Dr Luca Moretti

Low cardiac output syndrome is a clinical and hemodynamic condition in which the heart does not generate systemic flow adequate for metabolic requirements, with signs of hypoperfusion or a need for interventions to maintain perfusion. It is described mainly after cardiac surgery, but may complicate infarction, heart failure, myocarditis, valvular diseases, arrhythmias, and right ventricular failure. There is no universal definition: studies variably combine cardiac index, blood pressure, lactate, urine output, venous oxygen saturation, and use of inotropes or support. A cardiac index threshold below 2.0-2.2 L/min/m² is common, but alone does not distinguish appropriate cardiac output from insufficient perfusion. Diagnosis is therefore clinical and hemodynamic and serial. It must demonstrate inadequate flow, identify its mechanism, and rapidly distinguish a preload deficit, pump failure, excessive afterload, rhythm disturbance, and vasoplegia.

Low cardiac output and cardiogenic shock are not synonymous. A compensated reduction may present with preserved blood pressure and no organ damage, whereas shock implies circulatory failure with tissue hypoperfusion; vasodilation, hemorrhage, or tamponade may also coexist postoperatively. Cardiac output is the product of heart rate and stroke volume. Stroke volume depends on preload, contractility, afterload, synchrony, valvular function, and ventricular interaction: correcting the dominant determinant is more effective than indiscriminately increasing catecholamines. Early recognition limits progression to multiorgan dysfunction. Echocardiography, invasive pressure monitoring, lactate trends, and the response to targeted interventions must proceed together, with timely escalation when reserve does not recover.

Etiology, pathogenesis, and pathophysiology

After cardiopulmonary bypass, ischemia-reperfusion, cardioplegia, edema, and the inflammatory response may produce transient myocardial stunning; risk increases with reduced preoperative function, urgent surgery, prolonged cross-clamp times, reoperation, and valvular or combined surgery. Incomplete myocardial protection, coronary ischemia, air or procedure-related embolism, dissection, and graft occlusion instead cause persistent injury. New regional wall motion abnormalities, arrhythmias, ST elevation, and disproportionate troponin elevation require urgent coronary investigation; distinguishing reversible stunning from correctable ischemia changes prognosis and strategy. Waiting while increasing inotrope doses may lose the window for surgical revision, angiography, or mechanical support.

Insufficient preload results from bleeding, vasodilation, diuresis, anesthetic-induced venodilation, or impeded filling. Tamponade, a loculated hematoma, and tension pneumothorax may lack classic signs and are immediately reversible mechanical causes. Overload is equally harmful: it dilates the right ventricle, shifts the septum, increases tricuspid regurgitation and venous pressure, and reduces left ventricular compliance. The Frank-Starling curve in an impaired ventricle becomes flat, so additional volume increases congestion without increasing stroke volume; fluid responsiveness is not synonymous with a need for fluids. Even a fluid-responsive patient may not benefit if oxygenation, edema, or venous pressure makes the balance unfavorable.

Left ventricular failure may be systolic, diastolic, or both. Hypertrophy, ischemia, and tachycardia reduce filling; a small, stiff ventricle develops high pressures with modest volume, while a dilated one generates insufficient stroke volume despite high preload. Elevated systemic afterload, excessive vasoconstriction, or mismatch after correction of valvular regurgitation reduces stroke volume. Conversely, in vasoplegia, measured cardiac output may be normal or elevated but inadequate for demand and microcirculatory distribution; the combination of a weak pump and low resistance is common after bypass. It requires blood pressure supported by a vasopressor and adequate cardiac output, not a binary interpretation as cardiac or distributive shock.

The right ventricle is vulnerable to ischemia, embolism, hypoxia, acidosis, ventilation at high pressures, and increased pulmonary vascular resistance. After LVAD implantation or transplantation, a sudden increase in venous return or right ventricular-pulmonary arterial uncoupling may cause severe low cardiac output; right ventricular dilation reduces left ventricular filling through interdependence and increases hepatic and renal congestion. Elevated jugular venous pressure, a pulsatile liver, relatively clear lung fields, and a high RAP/PCWP ratio suggest right-sided predominance. Pulmonary hypertension, protamine, transfusions, and endothelial dysfunction may precipitate a crisis. Correction of hypoxia and acidosis, protective ventilation, and selective pulmonary vasodilators reduce afterload.

Atrial fibrillation, junctional tachycardia, atrioventricular block, and dyssynchrony eliminate the atrial contribution or coordination. In stiff ventricles, a seemingly tolerable heart rate may drastically reduce filling and cardiac output. Anemia, hypoxemia, fever, shivering, and pain increase requirements and turn marginal cardiac output into inadequate output; oxygen delivery depends on cardiac output, hemoglobin, and oxygen saturation: correcting only one of the three may not restore aerobic metabolism. Catecholamines increase contractility but also oxygen consumption, arrhythmias, and lactate; prolonged exposure promotes tachyphylaxis, myocardial damage, and organ vasoconstriction.

Clinical manifestations

Signs include cold extremities, delayed capillary refill, a narrow pulse pressure, oliguria, altered mental status, and rising lactate; blood pressure may remain normal through vasoconstriction, particularly in early stages or in a hypertensive patient. The perfusion trajectory is more informative than an isolated value. Worsening urine output, consciousness, skin perfusion, and acidosis despite acceptable blood pressure indicates inadequate or maldistributed flow. Subjective findings are absent in a sedated and ventilated patient. Peripheral temperature, urine output, blood gases, ultrasound, and drug doses become essential indicators.

Dyspnea, crackles, hypoxemia, and frothy secretions indicate increased left-sided pressures; jugular venous distention, edema, hepatomegaly, and ascites indicate systemic congestion; absence of edema does not exclude an acute episode. A new murmur, hepatic pulsation, or a pressure gradient may signal acute regurgitation, a septal defect, or dynamic obstruction; postoperative loculated tamponade may compress a single chamber and escape traditional examination. Bleeding through drains, falling hemoglobin, and transfusion requirements point toward hypovolemia; a drain that suddenly stops does not exclude an intrapericardial collection.

Low cardiac output due to right heart failure may be associated with hypotension, elevated venous pressure, oliguria, and low venous oxygen saturation, often with uncongested lungs. A dilated right ventricle and small left ventricle are characteristic findings but depend on ventilation and volume. In left heart failure, pulmonary edema and elevated wedge pressure predominate; the biventricular profile combines pulmonary and systemic congestion and responds less to strategies directed at a single chamber. A warm patient with low blood pressure, a wide pulse pressure, and cardiac output that is not reduced suggests vasoplegia; mixed forms show variable skin findings and a simultaneous need for an inotrope and a vasopressor.

Elevated lactate reflects hypoperfusion but also epinephrine, reduced hepatic clearance, seizures, and drugs; a persistent rise is unfavorable; a rapid fall after correction supports reversibility of the deficit. Low central venous oxygen saturation indicates increased extraction or reduced delivery, but may be falsely normal in microcirculatory shunting; the venous-to-arterial CO2 difference may signal insufficient flow when oxygen findings are ambiguous. Creatinine and aminotransferases rise late. Oliguria, coagulopathy, and altered mental status often precede conventional markers.

The course may be transient, persistent, or progressive. Stunning tends to improve in the first hours or days, while uncorrected ischemia, mechanical lesions, and perioperative infarction produce increasing dependence on support. Failure to reduce inotropes, lactate that does not normalize, and involvement of new organs define an inadequate response; stability achieved with toxic doses is not recovery. Documentation must describe the mechanism, chambers involved, congestion, perfusion, vasoactive dose, and support; the LCOS label alone is insufficient to guide handover.

Investigations and diagnosis

Initial assessment includes ECG, temperature, invasive blood pressure, blood gas analysis, lactate, complete blood count, electrolytes, kidney and liver function, coagulation, and injury markers; trends are correlated with drain output, fluid balance, bypass, and operative details. Bedside echocardiography evaluates volumes, global and regional contractility, the right ventricle, valves, septum, pericardium, and aorta. After surgery, transesophageal imaging is often necessary because of poor acoustic windows, prostheses, and posterior collections; the diagnostic question must be specific: hypovolemia, tamponade, ischemia, valvular regurgitation, obstruction, or right or left ventricular dysfunction. Repeating the examination after intervention is part of diagnosis.

Cardiac output may be estimated using thermodilution, the Fick principle, Doppler, or pulse contour analysis. Tricuspid regurgitation, shunts, respiratory variations, low perfusion, and assumptions about oxygen consumption generate clinically relevant errors; cardiac index must be interpreted alongside mean pressure, venous oxygen saturation, lactate, and cardiac work. An index below threshold without hypoperfusion may require observation, while higher values do not exclude inadequate oxygen delivery in anemia or sepsis; cardiac power output integrates pressure and flow; stroke volume index and pulse pressure describe ejection. No parameter replaces multiparametric consistency.

The pulmonary artery catheter provides RAP, pulmonary pressure, wedge pressure, cardiac output, and vascular resistance and allows underfilling, left-sided failure, right-sided failure, and mixed vasoplegia to be distinguished. It is useful in refractory cases, severe pulmonary hypertension, and during mechanical support. Zeroing, level, damping, and wedge position must be checked; end-expiratory measurement and waveform assessment reduce errors, but high PEEP and an open chest alter interpretation. Trends after pacing, a bolus, a vasopressor, or a ventilation change provide causal information; measurements must not delay surgical revision in probable tamponade.

Fluid responsiveness may be assessed with passive leg raising, a mini-fluid challenge, stroke volume variation, or end-expiratory occlusion; pulse pressure variation is valid only with a regular rhythm, controlled ventilation, and appropriate technical conditions. Isolated central venous pressure does not predict response, but describes congestion and back pressure; a high value with a dilated right ventricle makes benefit from further boluses unlikely. Lung ultrasound and extravascular fluid balance complement assessment of fluid tolerance. Responsiveness and tolerance are separate decisions.

ST changes, arrhythmias, new regional wall motion abnormalities, and instability may require immediate coronary angiography. CT is reserved for dissection, embolism, or bleeding when transport is safe; radiography checks the lungs, tubes, and complications. The differential diagnosis includes septic shock, a protamine reaction, anaphylaxis, adrenal insufficiency, embolism, pneumothorax, hemorrhage, and dynamic outflow tract obstruction. The latter worsens with inotropes and depletion and requires selective volume administration, reduced contractility, and increased afterload; comparison with the preoperative echocardiogram distinguishes a new lesion from chronic dysfunction. Multiple causes are more frequent than a single pure mechanism.

Treatment and prognosis

The priority is to correct the reversible cause: bleeding control, tamponade drainage, revascularization, graft or valve revision, arrhythmia treatment, and reduction of pulmonary afterload. Supporting blood pressure without correcting the anatomy prolongs injury. Oxygenation, temperature, calcium, pH, potassium, and magnesium are normalized; atrioventricular pacing or biventricular pacing may increase cardiac output by restoring heart rate and synchrony without additional catecholamine. Sedation, analgesia, and ventilation reduce oxygen consumption, but induction and PEEP may precipitate collapse. Every change is accompanied by hemodynamic monitoring.

Volume is administered in small aliquots with a goal and a stopping rule. Hemorrhage requires hemostasis and guided transfusion therapy, while overload with high filling pressure requires diuretics or selected ultrafiltration. Norepinephrine supports blood pressure in vasoplegia or hypotension; vasopressin may reduce catecholamine requirements; an individualized perfusion pressure considers chronic hypertension, the kidneys, the brain, and afterload risk. Use of fluids or vasopressors is not decided by blood pressure alone; cardiac output and congestion must improve in parallel.

Dobutamine, milrinone, and levosimendan increase cardiac output through different mechanisms, but none has demonstrated a universal survival advantage. Milrinone and levosimendan cause vasodilation and may be useful with high pulmonary afterload, but cause hypotension; milrinone accumulates in kidney failure. Dobutamine is rapidly titratable but increases heart rate and oxygen consumption. Epinephrine is potent but promotes tachyarrhythmias and drug-induced hyperlactatemia; it should be reserved for selected scenarios; the choice depends on blood pressure, right heart function, vascular resistance, beta-blocker therapy, kidney function, and rhythm. The minimum dose is used, and the possibility of reduction is reassessed early.

Inhaled nitric oxide or prostacyclins selectively reduce right ventricular afterload, particularly after surgery, transplantation, or LVAD implantation. Correction of hypoxia, hypercapnia, acidosis, and ventilatory pressures is equally important. IABP reduces afterload and improves coronary perfusion with modest support; a microaxial pump, VA-ECMO, and right ventricular support provide different profiles; support selection depends on the chamber, oxygenation, anatomy, goal, and reversibility. Escalation must not wait for extreme doses, very high lactate, or multiorgan failure; a multidisciplinary team defines eligibility, cannulation, and success criteria.

Weaning requires a corrected cause, stable rhythm, reduced vasoactive drugs, adequate perfusion, and sufficient function during gradual support reduction. Ultrasound and invasive measurements detect distention, right heart failure, or loss of blood pressure; prognosis depends on age, urgency, preoperative function, bypass duration, cause, lactate, and the organs involved. Myocardial reversibility and the speed of correction are more important than a single ejection fraction. Persistence may require a bridge to recovery, LVAD, transplantation, or assessment of the proportionality of care; treatment goals are discussed early when comorbidities and neurological injury limit options.

Complications

Kidney failure results from low perfusion, venous pressure, hemolysis, inflammation, and nephrotoxic agents. Oliguria and overload may require continuous replacement therapy, but overly rapid removal reduces preload; cardiogenic liver injury combines congestion and hypoxia, with abnormal aminotransferases, bilirubin, and INR. It changes drug metabolism and bleeding risk. Intestinal ischemia, ileus, and bacterial translocation are serious complications. Pain, distention, and persistent lactate elevation require assessment even in a sedated patient.

Atrial and ventricular arrhythmias are both cause and consequence of ischemia, catecholamines, and electrolyte disturbances. Cardioversion, pacing, amiodarone or lidocaine, and trigger correction are adapted to the substrate; electrical storm may require deep sedation, sympathetic blockade, ablation, and support. Repeated shocks worsen function and oxygen consumption. Bradycardia and conduction block may persist after valve surgery. Epicardial leads and the permanent implantation strategy are managed according to the probability of recovery.

Pulmonary edema, pneumonia, atelectasis, and ventilator-induced injury prolong respiratory support; the PEEP needed for oxygenation may worsen right heart function, requiring a monitored compromise. Bleeding, coagulopathy, and thrombocytopenia result from surgery, bypass, anticoagulation, and devices; heparin-induced thrombocytopenia must be distinguished from postoperative consumption when timing and thrombosis are compatible. Hemolysis from pumps or circuits increases potassium, pigmenturia, and kidney injury. LDH, free hemoglobin, and device position guide correction.

Mechanical support causes limb ischemia, thrombosis, stroke, infection, and vascular injury. VA-ECMO may increase left ventricular afterload, distend the ventricle, and aggravate edema; differential perfusion threatens the heart and brain; device surveillance includes flows, pressures, access sites, distal perfusion, hemolysis, and imaging. An unrecognized complication may negate the benefit of support; removal entails bleeding and occlusion risks and is planned with hemostasis and vascular assessment, rather than being considered an administrative step.

Delirium, acquired weakness, malnutrition, infections, and pressure injuries increase with intensive care duration. Mobilization and nutrition begin when perfusion and devices permit; survivors may have persistent reduction in cardiac function, kidney dysfunction, cognitive deficits, and post-intensive care syndrome. Cardiology and rehabilitation follow-up checks recovery, rhythm, and secondary prevention therapy; accurate documentation of the cause avoids attributing every future episode to generic low cardiac output. The discharge plan must state residual function, interventions performed, and signs of relapse.